The diagnostic paradigm for Alzheimer's disease (AD) has rapidly shifted in the last five years as fluid-based biomarker testing has emerged as a reliable, accurate, and accessible means to detect amyloid pathology when evaluating a patient for...

Communicating imperative diagnoses effectively can often be a daunting challenge. It’s a crucial and delicate step that takes practice and know-how to do well and can be one of the most important actions taken with patients. That’s why a panel ...

Women make up a majority of the workforce in pathology yet lag behind men in leadership roles. What are the consequences of this for women working in pathology today, and what can be done?  In this episode of Inside the ...

Although molecular testing offers promising opportunities for diagnosis and targeted treatment of cancers, prostate cancer has lagged behind other types of cancer. Recently, homologous recombination repair testing in prostate cancer has provide...

As CRC affects younger and more diverse populations, emerging tests for CRC biomarkers provide enormous utility for diagnosis. However, misdiagnosis of CRC, shifting demographics of those afflicted with CRC, and patient unfamiliarity with sympt...